Patents by Inventor Benjamin A. Pinsky

Benjamin A. Pinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230295750
    Abstract: Methods and oligonucleotide reagents for diagnosing chikungunya virus and Zika virus infections are described. In particular, the invention relates to quantitative assays that can detect all lineages of chikungunya virus and Zika virus and distinguish chikungunya virus and Zika virus from each other as well as dengue virus and other arbovirus pathogens.
    Type: Application
    Filed: January 27, 2023
    Publication date: September 21, 2023
    Inventors: Benjamin A. Pinsky, Jesse Waggoner
  • Patent number: 11591660
    Abstract: Methods and oligonucleotide reagents for diagnosing chikungunya virus and Zika virus infections are described. In particular, the invention relates to quantitative assays that can detect all lineages of chikungunya virus and Zika virus and distinguish chikungunya virus and Zika virus from each other as well as dengue virus and other arbovirus pathogens.
    Type: Grant
    Filed: January 14, 2017
    Date of Patent: February 28, 2023
    Assignee: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
    Inventors: Benjamin A. Pinsky, Jesse Waggoner
  • Publication number: 20190024195
    Abstract: Methods and oligonucleotide reagents for diagnosing chikungunya virus and Zika virus infections are described. In particular, the invention relates to quantitative assays that can detect all lineages of chikungunya virus and Zika virus and distinguish chikungunya virus and Zika virus from each other as well as dengue virus and other arbovirus pathogens.
    Type: Application
    Filed: January 14, 2017
    Publication date: January 24, 2019
    Inventors: Benjamin A. Pinsky, Jesse Waggoner
  • Patent number: 10093994
    Abstract: Methods and oligonucleotide reagents for diagnosing dengue virus infection are described. In particular, the invention relates to methods for detection, quantitation, and serotyping dengue virus, including serotypes 1-4. The dengue virus can be specifically detected by these methods even in samples containing other viruses, such as West Nile virus, Japanese encephalitis virus, tick-born encephalitis virus, HIV, or HCV.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: October 9, 2018
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Benjamin Pinsky, Jesse Waggoner
  • Publication number: 20170306425
    Abstract: Methods and oligonucleotide reagents for diagnosing dengue virus infection are described. In particular, the invention relates to methods for detection, quantitation, and serotyping dengue virus, including serotypes 1-4. The dengue virus can be specifically detected by these methods even in samples containing other viruses, such as West Nile virus, Japanese encephalitis virus, tick-born encephalitis virus, HIV, or HCV.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 26, 2017
    Inventors: Benjamin Pinsky, Jesse Waggoner
  • Patent number: 9725774
    Abstract: Methods and oligonucleotide reagents for diagnosing dengue virus infection are described. In particular, the invention relates to methods for detection, quantitation, and serotyping dengue virus, including serotypes 1-4. The dengue virus can be specifically detected by these methods even in samples containing other viruses, such as West Nile virus, Japanese encephalitis virus, tick-born encephalitis virus, HIV, or HCV.
    Type: Grant
    Filed: October 3, 2013
    Date of Patent: August 8, 2017
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Benjamin Pinsky, Jesse Waggoner
  • Publication number: 20150225802
    Abstract: Methods and oligonucleotide reagents for diagnosing dengue virus infection are described. In particular, the invention relates to methods for detection, quantitation, and serotyping dengue virus, including serotypes 1-4. The dengue virus can be specifically detected by these methods even in samples containing other viruses, such as West Nile virus, Japanese encephalitis virus, tick-born encephalitis virus, HIV, or HCV.
    Type: Application
    Filed: October 3, 2013
    Publication date: August 13, 2015
    Applicant: Board of Trustees of the Leland Standford Junior University
    Inventors: Benjamin Pinsky, Jesse Waggoner